Tata Sons Listing Debate, NSE IPO, Fed Rate Hike, UPI Charges And FDA Crackdown: Key Developments That Shaped The Week
Tata Sons’ possible public listing remained in focus as Shapoorji Pallonji Group backed the move, while the ₹22,568.94-crore NSE IPO drew stronger demand. The...